MERGE microbial strain improvement technique

MERGE uses non-GMO techniques to turn probiotics into therapeutics and reliable, commercial strains

MERGE is a patented strain improvement technique which used a type of directed evolution resulting in new phenotypes and antimicrobials. It turns mediocre results into repeatable and reliable results.

SciBac has used MERGE to create 2 novel lung therapeutics with multiple mechanisms designed to clear chronic lung infections in cystic fibrosis.

Technology:
  • Infection prevention
  • Antimicrobial stewardship
  • Alternative antimicrobials
  • Microbial diagnostics
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Fungi
  • Yeasts
  • Parasites
  • Viruses

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Company
  • Academia
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Joint Venture
  • Sell
  • Outsource

Funding organisation: WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.